The main viewpoints of the paper are as follows:

01 Prospective future for the medical aesthetics and medical market in GBA and China

With a view of the fragmented market landscape, the company, being the pioneer in medical aesthetics, is expected to capture market shares increasingly in the mainland market. Its leading position as Hong Kong’s largest non-hospital medical service provider further empowers the proposition of achieving rapid growth through market integration.

02 Wide moat with distinctive competitive advantages

(1) Rich brand equity to create an enclosed ecosystem from beauty to health; (2) flexible use of digital management to improve customer stickiness; and (3) diversified business matrix through acquisitions at attractive valuations, empowered by management’s sophisticated experience in M&A and post-integration.

03 Catalyst for growth

(1) Bright outlook for the Hong Kong medical aesthetics and medical market; (2) accelerating the strategic layout of GBA through expansion; and (3) business development from veterinary care to other emerging high growth sectors.